Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK-J1 是一种高效的 H3K27 组蛋白去甲基化酶抑制剂,在无细胞试验中对 JMJD3 (KDM6B) 和 UTX (KDM6A) 的 IC50 分别为 28 nM 和 53 nM,比其他测试的去甲基化酶选择性高 10 倍以上。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 149 | 现货 | ||
5 mg | ¥ 332 | 现货 | ||
10 mg | ¥ 534 | 现货 | ||
25 mg | ¥ 863 | 现货 | ||
50 mg | ¥ 1,560 | 现货 | ||
100 mg | ¥ 2,610 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 588 | 现货 |
产品描述 | GSK-J1 is a highly potent H3K27 histone demethylase inhibitor with IC50 of 28 nM and 53 nM in cell-free assays for JMJD3 (KDM6B) and UTX (KDM6A), respectively, >10-fold selectivity over other tested demethylases. |
靶点活性 | JMJD3 (KDM6B):28 nM, UTX (KDM6A):53 nM |
体外活性 | In HEK-293 cells, GSK-J1 inhibits the activities of transiently transfected JMJD3 and UTX. GSK-J1 also inhibits TNF-α production by human primary macrophages by increasing total nuclear H3K27me3 levels. [1] In MC3T3-E1 cells, GSK-J1 suppresses Runx2 and Osterix expressions and ALP activity, and increases the global levels of H3K27me3. [2] |
激酶实验 | Purified JmjD3 (1 μM) and UTX (3 μM) is incubated with 10 μM peptide [BiotinKAPRKQLATKAARK(me3 )SAPATGG] in 50 mM HEPES pH 7.5, 150 mM KCl, 50 μM (NH4)2SO4·FeSO4·Water, 1 mM 2-oxoglutarate, and 2 mM ascorbate (JmjD3, 3 minutes at 25°C; UTX, 20 minutes at 25°C) with various concentration of the inhibitor (0, 0.005, 0.01, 0.02, 0.05, 0.1 μM). 10 mM EDTA is added to stop the reaction. The reaction is desalted by zip tip and spotted on a MALDI plate with α-cyano-4-hydroxycinnamic acid MALDI matrix. Samples are analysed on a MALDI-TOF R system. |
别名 | GSK J1 |
分子量 | 389.45 |
分子式 | C22H23N5O2 |
CAS No. | 1373422-53-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 38.9 mg/mL (100 mM)
DMSO: 38.9 mg/mL (100 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
Ethanol / DMSO | 1 mM | 2.5677 mL | 12.8386 mL | 25.6772 mL | 64.1931 mL |
5 mM | 0.5135 mL | 2.5677 mL | 5.1354 mL | 12.8386 mL | |
10 mM | 0.2568 mL | 1.2839 mL | 2.5677 mL | 6.4193 mL | |
20 mM | 0.1284 mL | 0.6419 mL | 1.2839 mL | 3.2097 mL | |
50 mM | 0.0514 mL | 0.2568 mL | 0.5135 mL | 1.2839 mL | |
100 mM | 0.0257 mL | 0.1284 mL | 0.2568 mL | 0.6419 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
GSK-J1 1373422-53-7 Chromatin/Epigenetic Histone Demethylase inhibit GSK J1 Inhibitor GSKJ1 GSK-J-1 inhibitor